Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System by Puddu, A. et al.
Research Article
Advanced Glycation End-Products and
Hyperglycemia Increase Angiopoietin-2 Production by
Impairing Angiopoietin-1-Tie-2 System
Alessandra Puddu ,1 Roberta Sanguineti ,1 Davide Maggi,1 Massimo Nicolò ,2,3
Carlo E. Traverso,2 Renzo Cordera,1 and Giorgio L. Viviani 1
1Department of Internal Medicine and Medical Specialties, University of Genova, Genova 16132, Italy
2Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Genova 16132, Italy
3Fondazione per la Macula Onlus, Genova 16132, Italy
Correspondence should be addressed to Alessandra Puddu; alep100@hotmail.com
Received 11 July 2019; Revised 11 October 2019; Accepted 18 October 2019; Published 11 November 2019
Academic Editor: Secundino Cigarran
Copyright © 2019 Alessandra Puddu et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The angiopoietin-Tie-2 system plays a crucial role in the maintenance of endothelial integrity. Hyperglycemia and advanced
glycation end-products (AGEs) are involved in endothelial cell dysfunction responsible of the pathogenesis of microvascular
complications of diabetes. Here, we investigated whether glycated serum (GS) or hyperglycemia (HG) affect the angiopoietin-
Tie-2 system in the microvascular endothelial cells HMEC-1. We found that culture for 5 days in the presence of AGEs and HG
(alone or in combination) decreased cell proliferation, increased reactive oxygen species (ROS) production, and reduced ratio
between the oxidized and the reduced form of glutathione. Since angiopoietin-1 (Ang-1) signaling regulates angiopoietin-2
(Ang-2) expression through inactivation of the forkhead transcription factor FoxO1, we investigated intracellular signaling of
Ang-1 and expression of Ang-2. HG and AGEs reduced phosphorylation of Akt and abrogated phosphorylation of FoxO1
induced by Ang-1 without affecting neither Tie-2 expression nor its activation. Furthermore, AGEs and/or HG induced nuclear
translocation of FoxO1 and increased Ang-2 production. In conclusion, we demonstrated that both hyperglycemia and AGEs
affect the angiopoietin-Tie-2 system by impairing Ang-1/Tie-2 signaling and by increasing Ang-2 expression. These results
suggest that therapeutic strategies useful in preventing or delaying the onset of diabetic vascular complications should be aimed
to preserve Ang-1 signaling.
1. Introduction
The angiopoietin-Tie-2 system plays a crucial role in vessel
maturation and quiescence and modulates the maintenance
of endothelial integrity [1]. The angiopoietin growth factor-1
(Ang-1), which is produced by perivascular cells, is an
endothelial-specific protective factor and contributes to vessel
integrity by activating the tyrosine kinase receptor Tie-2
expressed by endothelial cells [2]. Binding of Ang-1 to Tie-2
leads to different intracellular signals mainly mediated by the
phosphatidylinositol 3-kinase (PI3K)/Akt pathway [3], which
contribute to the maintenance of the resting phenotype
and regulate survival, migration, and permeability of endo-
thelial cells [4]. Conversely, the angiopoietin growth factor-2
(Ang-2), which is produced by the endothelial cells, acts
as a dominant negative ligand of Tie-2, thereby leading
to vessel-destabilization and favoring the proangiogenic
and inflammatory response to growth factors and cyto-
kines [5, 6]. Once produced, Ang-2 is stored in Weibel-
Palade bodies and is released in response to inflammatory
stimuli [4]. Interestingly, expression of Ang-2 is regulated
by Akt signaling activated by Ang-1 through phosphoryla-
tion and inactivation of the forkhead transcription factor
FoxO1 [7]. In turn, FoxO1 targets Ang-2, leading to a
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negative-feedback loop that results in reduced Ang-2 gene
expression [7, 8].
Type 2 diabetes mellitus, a metabolic disease character-
ized by chronic hyperglycemia and low-grade inflammation,
lead to several vascular complications [9]. It is well known
that chronic hyperglycemia leads to accelerate formation of
advanced glycation end-products (AGEs), a heterogeneous
group of compounds resulted from the nonenzymatic reac-
tion of reducing sugars with free amino group of proteins
[10]. AGEs may exert adverse effects through several mecha-
nisms, including the formation of the protein cross-link that
alters the structure and function of the extracellular matrix,
the production of reactive oxygen species (ROS), and the
interaction with specific receptors [11–13]. Furthermore,
AGEs are responsible for the “metabolic memory” [14].
The detrimental effects of hyperglycemia and AGEs have an
important role in the development and the severity of dia-
betic complications, also due to the impairment of antioxi-
dant defenses, such as glutathione [15–18].
Endothelial dysfunction, including defect in angiogene-
sis, increased endothelial permeability, elevated leukocyte
adhesion, and impaired nitric oxide action, is implicated in
vascular complications of diabetes [19, 20]. Recent findings
suggest that hyperglycemia may predispose to endothelial
dysfunction by affecting the angiopoietin-Tie-2 system [21].
The aim of this study was to investigate the effects of hyper-
glycemia and AGEs in regulating the angiopoietin-Tie-2
system in endothelial cells and to identify the possible
mechanisms responsible for this process.
2. Materials and Methods
2.1. Preparation of AGEs. Glycated serum (GS) was prepared
by adding 50mmol/L ribose to heat-inactivated (56°C for one
hour) FBS, as described previously [22]. Aliquots of FBS were
processed the same way but without ribose (nonglycated
serum (NGS)) and used for standard medium preparation.
Pentosidine content was evaluated as a measure of protein
glycation, as previously described [19]. The concentration
of pentosidine in the experimental media containing NGS
was 70 pmol/mL, whereas the concentration of pentosidine
in the experimental media containing GS was 400 pmol/mL
which corresponds to the levels within the pathophysiologi-
cal range detected in the plasma of diabetic patients.
2.2. Cell Culture and Experimental Conditions.HMEC-1 cells
derived from human dermal microvascular endothelium
were purchased from ATCC (Manassas, VA). Cells were cul-
tured in MCDB131 medium supplemented with 10 ng/mL
epidermal growth factor, 1 μg/mL hydrocortisone, 10mM
glutamine, and 10% FBS. The medium was replaced every 2
days. Cells were grown to confluence, removed with
Trypsin-EDTA (Sigma-Aldrich, Milan, Italy), and then
seeded in multiwell plates for all experiments. Before each
experiment, confluent cells were washed twice with PBS
(Cambrex Bio Science) and then cultured in standardmedium
(CTR), in the presence of glycated serum (AGEs), 25mM
glucose (HG), and with their combination (AGEs+HG).
2.3. Cell Viability. To evaluate cell proliferation, HMEC-1
cells were plated in a 96-well plate (2 × 104 cells/well) and
cultured for 5 days as described above. Cell proliferation rate
was determined using the Cell Titer 96 Aqueous One
Solution Cell Proliferation Assay (Promega, Milan, Italy)
according to the manufacturer’s instructions. Briefly, it is a
colorimetric method that determines the number of viable
cells via MTS tetrazolium reduction into a colored formazan
product directly proportional to the number of living cells in
culture [22]. Values were expressed as arbitrary units.
2.4. Reactive Oxygen Species Detection. Intracellular reactive
oxygen species (ROS) level was measured using the cell-
permeable fluorescent probe, 2′,7′-dichlorofluorescein dia-
cetate (DCFH-DA) (Sigma-Aldrich, Milan, Italy). In brief,
cells were seeded into 6-well culture plates and treated
for 5 days as previously described, then washed twice with
Hank’s buffered salt solution (HBSS) and incubated with
fresh DCFH-DA (25 μM) in HBSS for 30min at 37°C in
5% CO2. After that, cells were washed twice in HBSS,
and wells were filled with 1mL HBSS before fluorescence
acquisition in a plate reader (TECAN InfinitePro200)
(Ex : λ485/Em : λ535 nm). Fluorescent emission was nor-
malized to total protein content. Results were expressed as
arbitrary units.
2.5. Ratio between the Oxidized (GSSG) and the Reduced
(GSH) Form of Glutathione. To evaluate the intracellular
content of glutathione (GSH), cells were plated in 6-well
dishes and cultured as described above. Quantification of
glutathione was performed using Cayman’s GSH askay Kit
according to the manufacturer’s instructions as previously
reported [23].
2.6. Cell Lysis and Ang-1-Tie-2 Signaling. At the end of the
experiments, a set of HMEC-1 cells was lysed in RIPA buffer
(50mmol/l Tris HCl pH7.5, 150mmol/l NaCl, 1%NP40, and
0.1% SDS), supplemented with protease and phosphatase
inhibitors. Another set of HMEC-1 cells was incubated in
endothelial cell basal medium lacking FBS or growth supple-
ments. After 2 hours, cells were exposed for 30min to PBS
(control) or Ang-1 (200 ng/ml). Medium was removed and
the cells were lysed in RIPA buffer. Cell lysates were assayed
for phosphorylated and total levels of Tie-2 receptors, Akt,
and FoxO1 using immunoblotting. Protein concentration of
each sample was determined using BCA Protein Assay Kit
(Pierce Biotechnology, Rockford, IL, USA).
2.7. Cell Lysis and Subcellular Fractionation. At the end of
each experiments, a set of HMEC-1 cells was lysed in
RIPA buffer, supplemented with protease and phosphatase
inhibitors. Another set of HMEC-1 cells was processed for
subcellular fractionation using the Subcellular Protein
Fractionation Kit (Pierce Biotechnology, Rockford, IL,
USA) according to the manufacturer’s instructions. Briefly,
various cellular compartments were isolated by sequential
addition of different extraction buffers to the cell pellet.
Each subcellular fraction was collected after centrifugation
and stored at -80°C. Protein concentration of each sample
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was determined using BCA Protein Assay Kit (Pierce
Biotechnology, Rockford, IL, USA).
2.8. Immunoblotting Analysis. Equal protein amounts of total
cell lysate, cytosolic, and nuclear fractions were separated on
4-20% SDSPAGE and transferred onto nitrocellulose. Filters
were blocked in 5% nonfat dried milk and incubated over-
night at 4°C with primary specific antibodies (anti-β-actin,
anti Akt, anti-phospho-Akt (Ser473), anti-angiopoietin-2,
anti-FoxO1, anti-phospho-FoxO1 (Ser256), anti-GAPDH,
anti-Histone H3, anti-Tie-2, and anti-phospho-Tie-2 (Tyr992)
fromCell Signaling Technology, Beverly, MA, USA). Secondary
specific horseradish peroxidase-linked antibodies were added
for 1 h at room temperature. Bound antibodies were detected
using the enhanced chemiluminescence lighting system (ECL
Plus), according to the manufacturer’s instructions. Each
membrane was stripped (Restore PLUS Western Blot
Stripping Buffer, Pierce Biotechnology, Rockford, IL, USA)
and probed for β-actin to verify equal protein loading. Bands
of interest were quantified by densitometry using the Alliance
software. Results were expressed as percentages of CTR
(defined as 100%).
2.9. Statistical Analysis. The results are representative of at
least 3 experiments. All analyses were carried out with the
GraphPad Prism 4.0 software (GraphPad Software, San
Diego, CA, USA). Data were expressed as the mean ± SEM
and then analyzed using one-way ANOVA followed by
Bonferroni’s multiple comparison test. A p value of <0.05
was considered statistically significant.
3. Results
3.1. AGEs and HG Decrease Cell Viability and Increase
Oxidative Stress. Firstly, we investigate whether diabetic
condition affect viability of endothelial cells, and we found
that culture of HMEC-1 cells for 5 days with AGEs, HG, or
their combination significantly reduced cell proliferation
(Figure 1(a)). Reactive oxygen species (ROS) are reactive
intermediates of molecular oxygen that act as important
second messengers within the cells. An imbalance between
generation of reactive ROS and antioxidant defense systems
represents the primary cause of endothelial dysfunction.
The incubation of HMEC-1 with AGEs or HG significantly
increase ROS intracellular production as compared to cells
incubated with control medium (Figure 1(b)).
Glutathione (GSH) is one of the most important and
potent antioxidants capable of preventing damage caused
by ROS by maintaining redox balance [24]. In the presence
of oxidative stress, it is oxidized to the disulphide dimer
GSSG. As shown in Figure 1(c), exposure of HMEC-1 cells
to AGEs, HG, or their combination induced a reduction of
the GSH/GSSG ratio.
3.2. Treatment with AGEs and HG Affects Ang-1 Signaling.
During physiological process, ROS act as important media-









































































Figure 1: Cell viability and oxidative stress in HMEC-1 cells cultured for 5 days in standard medium (CTR), in the presence of glycated serum
(AGEs), 25mM glucose (HG), and with their combination (AGEs+HG). (a) Cell proliferation rate (n = 4, ∗p < 0:05 and ∗∗p < 0:01 vs. CTR).
(b) Evaluation of intracellular ROS production (n = 4, ∗∗∗p < 0:001 vs. CTR) (c) Ratio between the reduced (GSH) and the oxidized (GSSG)
forms of glutathione (n = 4, ∗p < 0:05 and ∗∗p < 0:01 vs. CTR). Values shown indicate the mean SEM of at least 3 independent experiments.
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cellular differentiation and maintenance of homeostasis [25].
However, overproduction of ROS contributes to endothelial
dysfunction. To verify whether increased ROS production
and reduction of the GSH/GSSG ratio is associated with
impaired Ang-1 signaling, we investigated expression of
Tie-2 and activation of Ang-1 signaling cascade.
Culture of HMEC-1 cells with AGEs, HG, or their combi-
nation did not affect expression of Tie-2 (Figure 2(a)).
When HMEC-1 cells are cultured under standard condi-
tion, angiopoietin-1 induces an about threefold increment of
Tie-2 phosphorylation in comparison with unstimulated
cells. Culture with AGEs or HG did not affect the ability of
angiopoietin-1 to induce phosphorylation of Tie-2; however,
the combination of AGEs and HG significantly reduced
Ang-1 induced Tie-2 phosphorylation (Figure 2(b)).
Akt is considered a major angiogenic downstream medi-
ator of the Ang-1-Tie-2 signaling pathway [3]. Stimulation of
HMEC-1 cells with Ang-1 induced a strong increase of Akt
phosphorylation. Treatment with AGEs or HG reduced
phosphorylation of Akt induced by Ang-1; combination of
AGEs and HG further impaired the ability of Ang-1 to phos-
phorylate Akt (Figure 3(a)).
Ang-1-induced Akt activation is a potent inhibitor of
FoxO1 [7]. Therefore, we investigated FoxO1 phosphoryla-
tion under Ang-1 stimulation. In control condition, phos-
phorylation of FoxO1 increased of about 2.5-fold when cells
are stimulated with Ang-1. On the contrary, we did not
observe any significant increase of FoxO1 phosphorylation
when cells are cultured in diabetic milieu (Figure 3(b)).
Phosphorylation of FoxO1 leads to nuclear exclusion
[26]. To verify whether inability of Ang-1 to induce FoxO1
phosphorylation affects its cellular localization, we investi-
gate subcellular fractions of HMEC-1 cells. Here, we found
that HG and AGEs reduced localization of FoxO1 in the
cytosolic fraction and induced its translocation into the
nucleus (Figures 4(a) and 4(b)), leading to increased ratio
between the nuclear and the cytosolic fraction (Figure 4(c)).
FoxO1 is a positive regulator of Ang-2 transcription [8];
thus, we analyzed the expression of Ang-2. Intracellular con-
tent of Ang-2 is significantly increased by both AGEs and HG
(Figure 4(d)).
4. Discussion
In this study, we show that hyperglycemia and AGEs impair
the intracellular signaling cascade induced by Ang-1 through
activation of FoxO1 thus leading to increased Ang-2 produc-
tion in the microvascular endothelial cell line HMEC-1.
Although AGEs and HG have additive detrimental effects,
no significant difference has been found between effects of
AGEs and those of HG, confirming that AGEs are deleterious
as much as hyperglycemia.
It is well known that generation of oxidative stress by
hyperglycemia and AGEs is responsible of endothelial cell
dysfunction, cause of microvascular complications of diabe-
tes [27]. Another important role in the etiology of diabetic
complications is played by glutathione deficiency [28]. Here,
we found that exposure to diabetic milieu increased oxidative
stress and altered the redox balance by increasing the ratio
between the oxidized and the reduced form of glutathione.
This condition may reduce the possibility to counteract
the rise in ROS production caused by hyperglycemia and
AGEs, further worsening endothelial function and impairing
cell proliferation.
Alteration of the angiopoietin-Tie-2 system has a key role
in the development of microvascular complication of diabe-
tes, mainly because Ang-1 is a potent vascular protective
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Figure 2: AGEs and HG did not alter the expression and phosphorylation of Tie-2. (a) Western immunoblotting of Tie-2 in HMEC-1 cells
cultured for 5 days in CTR, AGEs, HG, and HG+AGEs. (b) After the 5-day treatment described above, HMEC-1 cells were incubated for 2
hours in serum-free medium and, then, exposed for 30min to PBS (control) or Ang-1 (200 ng/ml). Then, Tie-2 and phosphoTie-2 were
analyzed. Representative western blot analysis and quantification of densitometries of western blot band. Data were expressed as mean ±
SEM of fold induction relative to β-actin (a) or to relative expression of Tie-2 and phTie-2 (b) (n = 4). ∗p < 0:05 and ∗∗∗p < 0:001 vs. same
culture condition in the absence of Ang-1.
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[29]. It has been reported that incubation of microvascular
endothelial cells with 30mM glucose affects the ability of
Ang-1 to activate Tie-2 receptor phosphorylation and inhibits
Ang-1-dependent Akt phosphorylation without any decrease
in Tie-2 expression [21]. A significant impairment of Ang-1-
induced Akt phosphorylation has been also found coupled
with downregulation of Tie-2 expression [30]. According to
the results of Singh et al. [21], we found that hyperglycemia
and AGEs impair the intracellular signaling cascade induced
by Ang-1 without changing in Tie-2 expression. However, in
our model, this occurs without affecting the ability of Ang-1
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Figure 3: AGEs andHG reduced phosphorylation of AKT and FoxO1 induced by Ang-1. After the 5-day treatment described above, HMEC-1
cells were incubated for 2 hours in serum-freemedium and, then exposed for 30min to PBS (control) or Ang-1 (200 ng/ml). Then, phAKT and
AKT (a) and phFoxO1 and FoxO1 (b) were analyzed. Representative western blot analysis and quantification of densitometries of western blot
band. Data were expressed as mean ± SEM of fold induction relative to unphosphorylated protein (n = 4). ∗∗∗p < 0:001 vs. the same culture

























































Figure 4: AGEs and HG increased expression of Ang-2. HMEC-1 cells were cultured for 5 days in standard medium (CTR), in the presence of
glycated serum (AGEs), 25mM glucose (HG), and with their combination (AGEs+HG). Western blot analysis of nuclear (a) and cytosolic
(b) localization of FoxO1. Histone H3 and GAPDH amounts were analyzed as loading controls. (c) Graph represents relative ratio between
nuclear and cytosolic fractions (n = 3, ∗p < 0:05 and ∗∗p < 0:01 vs. CTR). (d) Western immunoblotting of Ang-2. Representative western blot
analysis and quantification of densitometries of western blot band. Data were expressed asmean ± SEM of fold induction relative to β-actin.
Values shown indicate the mean SEM of at least 3 independent experiments (n = 3, ∗p < 0:5, ∗∗p < 0:01 and ∗∗∗p < 0:001 vs. CTR).
5Journal of Diabetes Research
condition impairs also the downstream signal transducers of
Tie-2. Akt, which is considered the major mediator of the
Tie-2 intracellular signaling pathway, regulates function of
endothelial cells, and promotes their survival [3]. Interest-
ingly, our data showed that phosphorylation of Akt is
significantly reduced by incubation with HG or AGEs,
despite expression and activation of Tie-2 by Ang-1 are
unchanged. DeBusk et al. demonstrated that Akt is required
and sufficient to mediate Ang-1-endothelial cell survival [3].
Therefore, the reduced ability of Ang-1 to induce Akt phos-
phorylation, in cells cultured with HG or AGEs, may
contribute, together with oxidative stress, to decrease EC
viability and function. Akt signaling plays also a key role
in regulating Ang-2 expression by deactivating the forkhead
transcription factor, FoxO1 [7]. Activity of FoxO1 is regu-
lated by posttranslational modifications, in particular, phos-
phorylation deactivates FoxO1 determining its cytoplasmic
localization [26]. In this study, we found that HG and
AGEs prevent phosphorylation of FoxO1 induced by Ang-1,
leading, at the same time, to increased translocation of
FoxO1 into the nucleus. As expected, increased localization
of FoxO1 in the nucleus is associated to a significant incre-
ment in production of Ang-2, suggesting that HG and AGEs
affect Ang-2 production in endothelial cells by activating
FoxO1. Reduced phosphorylation of FoxO1 by AGEs has
been observed also in pancreatic beta-cells [31], suggesting
the existence of a common mechanism through which AGEs
regulate gene transcription.
Once produced, Ang-2 is stored in Weibel-Palade bodies
and is released in response to inflammatory stimuli [4]. Clin-
ical studies revealed that the circulating levels of Ang-2 level
was increased in patients with diabetes [32, 33], and correlate
with vascular complications [29, 34]. The rise in Ang-2 may
contribute to destabilize the vasculature, leading to uncon-
trolled neovascularization, as occurs in the late stage of dia-
betic retinopathy, or defective angiogenesis, thus impairing
wound healing [29]. On the contrary, lower levels of Ang-1
have been found in patients with diabetes [35]. Therefore,
the increased Ang-2/Ang-1 ratio may contribute to nega-
tively affect Ang-1-Tie-2 signaling. Our results suggest that
HG and AGEs may induce a vicious circle in which the
impaired Ang-1 signaling leads to increased Ang-2 expres-
sion that, in turn, may contribute to further worsening
Ang-1 signaling.
5. Conclusions
In this study, we demonstrated that both hyperglycemia and
AGEs impair the angiopoietin-Tie-2 system by disrupting
Ang-1-Tie-2 signaling and by increasing Ang-2 production
via FoxO1 activation. Since Ang-2 can be rapidly released
after secretagogue stimulus, increased Ang-2 storage may
enhance the responsiveness of endothelial cells to inflamma-
tory or angiogenic cytokines. These results suggest that ther-
apeutic strategies useful in preventing or delaying the onset
of diabetic vascular complications should be aimed to pre-
vent formation of AGEs and to preserve Ang-1 signaling in
order to maintain tissue homeostasis.
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